Trial Profile
A Randomized, Open-label, Two-period Crossover Study in Healthy Male Subjects to Evaluate the Pharmacodynamic Effect of Darexaban (YM150) on Acetyl Salicylic Acid (ASA) and of Darexaban on the Combination of ASA and Clopidogrel at Steady State
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Mar 2013
Price :
$35
*
At a glance
- Drugs Darexaban (Primary) ; Aspirin; Clopidogrel
- Indications Pain; Rheumatic disorders; Thrombosis
- Focus Pharmacodynamics
- Sponsors Astellas Pharma
- 10 Aug 2011 New trial record